Putnam Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$393K Sell
5,503
-144
-3% -$10.3K ﹤0.01% 1007
2023
Q3
$338K Buy
+5,647
New +$338K ﹤0.01% 1036
2020
Q4
Sell
-40,436
Closed -$2.4M 832
2020
Q3
$2.4M Sell
40,436
-40,663
-50% -$2.42M ﹤0.01% 614
2020
Q2
$5.66M Buy
81,099
+42,100
+108% +$2.94M 0.01% 447
2020
Q1
$1.77M Sell
38,999
-21,086
-35% -$956K ﹤0.01% 646
2019
Q4
$3.91M Hold
60,085
0.01% 572
2019
Q3
$3.73M Sell
60,085
-4,139
-6% -$257K 0.01% 577
2019
Q2
$4.57M Hold
64,224
0.01% 539
2019
Q1
$5.04M Sell
64,224
-13,983
-18% -$1.1M 0.01% 506
2018
Q4
$6.62M Hold
78,207
0.02% 413
2018
Q3
$13.4M Buy
78,207
+46,004
+143% +$7.88M 0.03% 329
2018
Q2
$4.16M Sell
32,203
-8,308
-21% -$1.07M 0.01% 577
2018
Q1
$4.17M Buy
40,511
+9,049
+29% +$932K 0.01% 547
2017
Q4
$2.69M Sell
31,462
-233
-0.7% -$19.9K 0.01% 686
2017
Q3
$2.69M Buy
+31,695
New +$2.69M 0.01% 682
2017
Q2
Sell
-21,942
Closed -$1.45M 1208
2017
Q1
$1.45M Sell
21,942
-2,622
-11% -$173K ﹤0.01% 924
2016
Q4
$1.56M Sell
24,564
-116
-0.5% -$7.35K ﹤0.01% 900
2016
Q3
$1.57M Sell
24,680
-14,622
-37% -$931K ﹤0.01% 910
2016
Q2
$2.92M Buy
39,302
+14,582
+59% +$1.08M 0.01% 818
2016
Q1
$1.65M Buy
24,720
+497
+2% +$33.2K ﹤0.01% 994
2015
Q4
$1.64M Sell
24,223
-524
-2% -$35.5K ﹤0.01% 1027
2015
Q3
$1.32M Buy
24,747
+718
+3% +$38.4K ﹤0.01% 1099
2015
Q2
$1.51M Sell
24,029
-123
-0.5% -$7.75K ﹤0.01% 1130
2015
Q1
$1.16M Buy
+24,152
New +$1.16M ﹤0.01% 1173